KEISHA PERKINS: Open Payments
NPI 1548896335 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 8 payments from 5 companies in 2025. Trend: 2023 $282 · 2024 $184 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: QULIPTA, UBRELVY, AIRSUPRA, MOUNJARO, VRAYLAR, Wegovy, CAPLYTA.
Industry payments across KY — which companies pay providers there.
